These QD formulations demonstrate enhanced sensitivity and selectivity in detecting biomarkers such as beta-hCG, P53, HER2/neu, and EpCAM, enabling the accurate assessment and imaging of breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.